NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Abolis

Abolis

Private
FranceHealthcare & Life Scienceshttps://www.abolis.fr/

Last Round

VC Round

Sep 12, 2024

Total Funding Raised

$2.23M

Company Overview

Abolis is a biotechnology company that specializes in bio-synthesis processes to optimize microorganism metabolism for the industrial production of complex molecular entities.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Fashion & Beauty, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic biologysynbiomicrobial engineeringbio-manufacturingstrain engineeringbio-based ingredientsbiotechbioprocess optimizationdesign-build-test-learnDBTLin-silico designcell factorysustainable chemistryrobotic screeningmetabolic engineeringbiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abolis Comparables

Compare Abolis with similar companies based on industry and business-model similarity.

Abolis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EV Biotech
83%
Acies Bio
83%
Amyris
80%

Abolis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 12, 2024
GrantNov 25, 2021

Key People

Founding team and executive leadership

Cyrille Pauthenier

Founder, Owner CEO

Founding Team

Thomas SACCONE

Interim CFO

Executive Team

Abolis Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 24, 2025

    Partnership valued at €140M as part of IPCEI Med4Cure funding.

Abolis Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Abolis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Abolis's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance
Employee Range67
Year Founded2014
Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.